Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-031636
Filing Date
2021-12-15
Accepted
2021-12-15 21:03:07
Documents
2
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3084
2 ex24-1.htm EX-24.1 19687
  Complete submission text file 0001493152-21-031636.txt   24122
Mailing Address 15378 AVENUE OF SCIENCE STE 100 SAN DIEGO CA 92128
Business Address
Adams Helen C. (Reporting) CIK: 0001488486 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41159 | Film No.: 211495714

Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Issuer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations